prednisone has been researched along with haloperidol in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (10.34) | 18.7374 |
1990's | 6 (20.69) | 18.2507 |
2000's | 14 (48.28) | 29.6817 |
2010's | 6 (20.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Lusins, JO; Szilagyi, PA | 1 |
Aladro, Y; Amérigo, MJ; Antolín, J; Artiles, J; Cárdenes, MA; Gómez, E | 1 |
de Glas-Vos, JW; Prins, JM | 1 |
Hutzler, JC; Sabet-Sharghi, F | 1 |
Dorsch, C; Malinow, KL | 1 |
Gershon, S; Kahaner, K; Kaufmann, M; Peselow, ED | 1 |
Broto Civera, E; Hortells Aznar, JL; Millán Sáez, L; Reclusa Poyo, FJ; Velilla Marco, J | 1 |
Abouesh, A; Hobbs, WR | 1 |
Ahmad, M; Rasul, FM | 1 |
del Valle-Villagrán, J; Fernández-López, I; Gómez-Herreros, R; Gotor Sánchez-Luengo, F | 1 |
Kahn, DA; Pelic, C; Shibley, H | 1 |
Estrugo-Devesa, A; Jané-Salas, E; López-López, J; Segura-Egea, JJ | 1 |
El Otmani, H; Fadel, H; Moutaouakil, F; Slassi, I | 1 |
Gibbs, EP; Gonzalez, R; Hodgins, GE; Nemeroff, C; Regan, J; Saltz, SB | 1 |
2 review(s) available for prednisone and haloperidol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Steroid-Induced Psychosis in the Pediatric Population: A New Case and Review of the Literature.
Topics: Adrenal Cortex Hormones; Antipsychotic Agents; Child; Female; Glucocorticoids; Haloperidol; Humans; Pediatrics; Prednisone; Psychoses, Substance-Induced | 2018 |
27 other study(ies) available for prednisone and haloperidol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Clinical features of chorea associated with systemic lupus erythematosus.
Topics: Adult; Azathioprine; Blood Sedimentation; Chlorpromazine; Chorea; Female; Haloperidol; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisone; Recurrence | 1975 |
[Chorea and systemic lupus erythematosus].
Topics: Adolescent; Chorea; Drug Therapy, Combination; Female; Haloperidol; Humans; Lupus Erythematosus, Systemic; Prednisone | 1990 |
[Cerebral disseminated lupus erythematosus; brain-racking for patient and physician].
Topics: Adult; Catatonia; Drug Therapy, Combination; Female; Haloperidol; Humans; Lupus Erythematosus, Systemic; Mutism; Neurocognitive Disorders; Prednisone | 1990 |
Prophylaxis of steroid-induced psychiatric syndromes.
Topics: Adult; Dibenzocycloheptenes; Female; Haloperidol; Humans; Lithium; Prednisone; Protriptyline; Substance-Related Disorders | 1990 |
Tricyclic precipitation of steroid psychosis.
Topics: Doxepin; Drug Interactions; Female; Haloperidol; Humans; Middle Aged; Prednisone; Psychoses, Substance-Induced | 1984 |
Steroid psychoses: case report and brief overview.
Topics: Adult; Dose-Response Relationship, Drug; Female; Giant Cell Arteritis; Haloperidol; Humans; Prednisone; Substance-Related Disorders | 1982 |
[Systemic lupus erythematosus and psychosis].
Topics: Aged; Anti-Inflammatory Agents; Antipsychotic Agents; Female; Haloperidol; Humans; Lupus Erythematosus, Systemic; Prednisone; Psychotic Disorders | 1998 |
Clarithromycin-induced mania.
Topics: Bipolar Disorder; Clarithromycin; Depressive Disorder; Female; Haloperidol; Humans; Lithium; Middle Aged; Prednisone; Sinusitis | 1998 |
Steroid-induced psychosis treated with haloperidol in a patient with active chronic obstructive pulmonary disease.
Topics: Anti-Inflammatory Agents; Antipsychotic Agents; Dermatitis; Dose-Response Relationship, Drug; Emergency Treatment; Female; Haloperidol; Humans; Lung Diseases, Obstructive; Middle Aged; Prednisone; Psychoses, Substance-Induced | 1999 |
[Fludrocortisone resistance in a patient with Addison disease and bipolar disorder treated with lithium].
Topics: Addison Disease; Adrenocorticotropic Hormone; Adult; Bipolar Disorder; Drug Interactions; Drug Resistance; Epilepsy, Tonic-Clonic; Fludrocortisone; Haloperidol; Humans; Hydrocortisone; Hyponatremia; Lithium Carbonate; Male; Prednisone | 2007 |
A case of paranoid schizophrenia complicated by scleroderma with associated esophageal dysmotility.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Case Management; Commitment of Mentally Ill; Cyclophosphamide; Diagnosis, Differential; Drug Interactions; Enteral Nutrition; Esophageal Achalasia; Female; Haloperidol; Humans; Immunosuppressive Agents; Olanzapine; Patient Acceptance of Health Care; Patient Care Team; Personality Assessment; Prednisone; Referral and Consultation; Schizophrenia, Paranoid; Scleroderma, Systemic; Treatment Refusal; Weight Loss | 2008 |
Inferior alveolar nerve injury resulting from overextension of an endodontic sealer: non-surgical management using the GABA analogue pregabalin.
Topics: Adult; Analgesics; Anti-Inflammatory Agents; Epoxy Resins; Female; Follow-Up Studies; Foreign Bodies; gamma-Aminobutyric Acid; Humans; Hypesthesia; Mandibular Nerve; Paresthesia; Periapical Periodontitis; Prednisone; Pregabalin; Root Canal Filling Materials; Root Canal Therapy; Trigeminal Nerve Injuries | 2012 |
Chorea paralytica: a videotape case with rapid recovery and good long-term outcome.
Topics: Adolescent; Anti-Bacterial Agents; Antipsychotic Agents; Chorea; Female; Glucocorticoids; Haloperidol; Humans; Methylprednisolone; Penicillin G; Prednisone; Treatment Outcome | 2013 |